Adult height, body mass index and time of menarche of girls with idiopathic central precocious puberty after gonadotropin-releasing hormone analogue treatment

References

• CrowleyWF Jr, ComiteF, ValeW, RivierJ, LoriauxDL, CutlerGB Jr. Therapeutic use of pituitary desensitization with a long-acting LHRH agonist: a potential new treatment for idiopathic precocious puberty. J Clin Endocrinol Metab 1981;52:370–372.
   PubMed Web of Science ®Google Scholar
• PasquinoAM, PucarelliI, AccardoF, DemirajV, SegniM, Di NardoR. Long-term observation of 87 girls with idiopathic central precocious puberty treated with gonadotropin-releasing hormone analog: impact on adult height, body mass index, bone mineral content, and reproductive function. J Clin Endocrinol Metab 2008;93:190–195.
   PubMed Web of Science ®Google Scholar
• BritoVN, LatronicoAC, CukierP, TelesMG, SilveiraLF, ArnholdIJ, MendoncaBB. Factors determining normal adult height in girls with gonadotropin-dependent precocious puberty treated with depot gonadotropin-releasing hormone analogs. J Clin Endocrinol Metab 2008;93:2662–2669.
   PubMedGoogle Scholar
• KleinKO, BarnesKM, JonesJV, FeuillanPP, CutlerGB Jr. Increased final height in precocious puberty after long-term treatment with LHRH agonists: the National Institutes of Health experience. J Clin Endocrinol Metab 2001;86:4711–4716.
   PubMed Web of Science ®Google Scholar
• HegerS, PartschCJ, SippellWG. Long-term outcome after depot gonadotropin-releasing hormone agonist treatment of central precocious puberty: final height, body proportions, body composition, bone mineral density, and reproductive function. J Clin Endocrinol Metab 1999;84:4583–4590.
   PubMed Web of Science ®Google Scholar
• ArrigoT, CisterninoM, GalluzziF, BertelloniS, PasquinoAM, AntoniazziF, BorrelliP, CrisafulliG, WasniewskaM, De LucaF. Analysis of the factors affecting auxological response to GnRH agonist treatment and final height outcome in girls with idiopathic central precocious puberty. Eur J Endocrinol 1999;141:140–144.
   PubMed Web of Science ®Google Scholar
• KletterGB, KelchRP. Effects of gonadotropin-releasing hormone analog therapy on adult stature in precocious puberty. J Clin Endocrinol Metab 1994;79:331–334.
   PubMed Web of Science ®Google Scholar
• OostdijkW, RikkenB, SchreuderS, OttenB, OdinkR, RouweC, JansenM, GerverWJ, WaelkensJ, DropS. Final height in central precocious puberty after long term treatment with a slow release GnRH agonist. Arch Dis Child 1996;75:292–297.
   PubMed Web of Science ®Google Scholar
• CarelJC, RogerM, IspasS, TonduF, LahlouN, BlumbergJ, ChaussainJL. Final height after long-term treatment with triptorelin slow release for central precocious puberty: importance of statural growth after interruption of treatment. J Clin Endocrinol Metab 1999;84:1973–1978.
   PubMed Web of Science ®Google Scholar
• PatersonWF, McNeillE, YoungD, DonaldsonMD. Auxological outcome and time to menarche following long-acting goserelin therapy in girls with central precocious or early puberty. Clin Endocrinol 2004;61:626–634.
   PubMedGoogle Scholar
• TraggiaiC, PerucchinPP, ZerbiniK, GastaldiR, De BiasioP, LoriniR. Outcome after depot gonadotrophin-releasing hormone agonist treatment for central precocious puberty: effects on body mass index and final height. Eur J Endocrinol 2005;153:463–464.
   PubMedGoogle Scholar
• PartschCJ, HummelinkR, SippellWG. Reference ranges of lutropin and follitropin in the luliberin test in prepubertal and pubertal children using a monoclonal immunoradiometric assay. J Clin Chem Clin Biochem 1990;28:49–52.
   Google Scholar
• PoomthavornP, KhlairitP, MahachoklertwattanaP. Subcutaneous gonadotropin-releasing hormone agonist (triptorelin) test for diagnosing precocious puberty. Horm Res 2009;72:114–119.
   Google Scholar
• BhatiaS, NeelyEK, WilsonDM. Serum luteinizing hormone rises within minutes after depot leuprolide injection: implications for monitoring therapy. Pediatrics 2002;109:E30.
   PubMed Web of Science ®Google Scholar
• Department of Health, Ministry of Public Health, Thailand. Reference for weight, height and nutritional indices in Thais aged 1 day to 19 years. Bangkok, Thailand: Department of Health, Ministry of Public Health, Thailand2000.
   Google Scholar
• TannerJM, GoldsteinH, WhitehouseRH. Standards for children's height at ages 2–9 years allowing for heights of parents. Arch Dis Child 1970;45:755–762.
   PubMed Web of Science ®Google Scholar
• WHO growth reference data for 5–19 years. 2007 WHO reference. Electronic citation. http://www.who.int/growthref/en/ Accessed 24 August 2009.
   Google Scholar
• MarshallWA, TannerJM. Variations in pattern of pubertal changes in girls. Arch Dis Child 1969;44:291–303.
   PubMed Web of Science ®Google Scholar
• GreulichWW, PyleSI. Radiographic atlas of skeletal development of the hand and wrist. 2nd ed. Stanford, CA: Stanford University Press1959.
   Google Scholar
• BayleyN, PinneauSR. Tables for predicting adult height from skeletal age: revised for use with the Greulich-Pyle hand standards. J Pediatr 1952;40:423–441.
   PubMed Web of Science ®Google Scholar
• KauliR, GalatzerA, KornreichL, LazarL, PertzelanA, LaronZ. Final height of girls with central precocious puberty, untreated versus treated with cyproterone acetate or GnRH analogue. A comparative study with re-evaluation of predictions by the Bayley-Pinneau method. Horm Res 1997;47:54–61.
   PubMed Web of Science ®Google Scholar
• AntoniazziF, ArrigoT, CisterninoM, GalluzziF, BertelloniS, PasquinoAM, BorrelliP, OsioD, MengardaF, De LucaF, End results in central precocious puberty with GnRH analog treatment: the data of the Italian Study Group for Physiopathology of Puberty. J Pediatr Endocrinol Metab 2000;13:773–780.
   Google Scholar
• CarelJC, LahlouN, RogerM, ChaussainJL. Precocious puberty and statural growth. Hum Reprod Update 2004;10:135–147.
   PubMed Web of Science ®Google Scholar
• BarA, LinderB, SobelEH, SaengerP, DiMartino-NardiJ. Bayley-Pinneau method of height prediction in girls with central precocious puberty: correlation with adult height. J Pediatr 1995;126:955–958.
   PubMed Web of Science ®Google Scholar
• ChiumelloG, BrambillaP, GuarneriMP, RussoG, ManzoniP, SgaramellaP. Precocious puberty and body composition: effects of GnRH analog treatment. J Pediatr Endocrinol Metab 2000;13:791–794.
   PubMedGoogle Scholar
• FeuillanPP, JonesJV, BarnesK, Oerter-KleinK, CutlerGB Jr. Reproductive axis after discontinuation of gonadotropin-releasing hormone analog treatment of girls with precocious puberty: long term follow-up comparing girls with hypothalamic hamartoma to those with idiopathic precocious puberty. J Clin Endocrinol Metab 1999;84:44–49.
   PubMed Web of Science ®Google Scholar
• ArrigoT, De LucaF, AntoniazziF, GalluzziF, SegniM, RosanoM, MessinaMF, LombardoF. Reduction of baseline body mass index under gonadotropin-suppressive therapy in girls with idiopathic precocious puberty. Eur J Endocrinol 2004;150:533–537.
   PubMedGoogle Scholar
• MagiakouMA, ManousakiD, PapadakiM, HadjidakisD, LevidouG, VakakiM, PapaefstathiouA, LaliotiN, Kanaka-GantenbeinC, PiaditisG, The efficacy and safety of gonadotropin-releasing hormone analog treatment in childhood and adolescence: a single center, long-term follow-up study. J Clin Endocrinol Metab 2010;95:109–117.
   PubMed Web of Science ®Google Scholar
• SchroorEJ, Van WeissenbruchMM, Delemarre-van de WaalHA. Long-term GnRH-agonist treatment does not postpone central development of the GnRH pulse generator in girls with idiopathic precocious puberty. J Clin Endocrinol Metab 1995;80:1696–1701.
   Google Scholar
• CarelJC, EugsterEA, RogolA, GhizzoniL, PalmertMR; AntoniazziF, BerenbaumS, BourguignonJP, ChrousosGP, CosteJ, ESPE-LWPES GnRH Analogs Consensus Conference GroupConsensus statement on the use of gonadotropin-releasing hormone analogs in children. Pediatrics 2009;123:e752–e762.
   PubMed Web of Science ®Google Scholar